An eLife report identifies that doubling the dolutegravir dosage may reduce the viral reservoir in HIV patients, with peer reviewers characterizing the finding as a "solid" indication. This study suggests treatment intensification can lower intact HIV DNA levels within three months, although the effect was not consistent across all participants. Read the full study at eLife . AI responses may include mistakes. Learn more
